Device Trial Radar · NCT03636230
Virtual E-health System for Pacemakers
Last checked: Nov 20, 2026Latest source record: Sep 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
848
Actual
Start
Sep 15, 2020
Primary completion
Apr 30, 2026
Study completion Jun 30, 2026
Sponsor
- Lead sponsor
- Ratika ParkashAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Cardiac Arrhythmia Network of Canada; Medtronic; Abbott
- First posted
- Aug 17, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
While remote monitoring (RM) technology is currently available and has permitted surveillance and device assessment from any patient location, the use has been inconsistent in Canada, where only 8500 out of a potential 120 000 patients with cardiac implantable electronic devices (CIEDs) are enrolled in this program. This technology is in widespread use worldwide for all CIEDs but in Canada, it is utilized primarily for implantable defibrillators, but not pacemakers. Whereas most of the trials were designed to evaluate the efficacy of RM in implantable cardioverter defibrillator (ICD) patients, in the pacemaker (PM) population, there has been work performed already to demonstrate an increase in detection of frequency of adverse clinical events and a reduction in reaction time to those events by RM. Based on all the available literature, it appears that RM benefits both patients and healthcare systems. Overall, studies have demonstrated that RM can be used safely in all device patient-populations, with the exception of pacemaker-dependent patients. There have been no studies that have evaluated RM only follow up, nor have there been any studies evaluating pacemaker-dependent patients. This study that will safely assess the use of RM only, with in-clinic visits when necessary, that uses the patient-centered electronic platform developed by the Cardiac Arrhythmia Network of Canada (CANet) to perform PM follow up safely, in a more cost-effective manner.
Conditions
- Pacemaker
Interventions
Remote MonitoringDevice
Remote Monitoring only + VIRTUES
Standard of careOther
In-Clinic visits only
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to major adverse cardiac event (MACE)Time frame: 18 months
- Cost effectivenessTime frame: 18 months
Locations
11 sites in 1 country. Site status is shown where the registry gives one.
Foothills Hospital
Calgary, Alberta, Canada
Victoria Cardiac Arrhythmia Trials
Victoria, British Columbia, Canada
Memorial University of Newfoundland Hospital
St. John's, Newfoundland and Labrador, Canada
8 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.